22 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States … or institutional review board and applicable state, national, or supra national agencies responsible for oversight.
(bb) Possession of Intellectual
8-K
EX-10.1
CGTX
Cognition Therapeutics Inc
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s … or Institutional Review Board and applicable state, national, or supra national agencies responsible for oversight.
(w) Health Care Products Manufacturing
S-3
EX-1.2
8427 l9sxk3sn
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
re1ee
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
g04b1ipnkp2t koiulcv
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
my0moc6u
20 Oct 22
Draft registration statement
12:00am
DEF 14A
cuk49
25 Apr 22
Definitive proxy
5:28pm
10-K
kpl34ngj 8i5v
30 Mar 22
Annual report
7:40am
10-Q
0zefrlrda6cur59 9y
17 Nov 21
Quarterly report
5:15pm
424B4
u0kabn t9p92c83
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
fah3xy
19 Jul 21
IPO registration
7:02am